The blockade of DAT generates an augmentation of dopamine in the synaptic cleft, improving neurological function disorders involved with emotional approaches, such as learning disabilities, anxiety, anhedonia, and depression [5]. The gene discussed is SLC6A3; the disease is depressive disorder.